These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18289690)

  • 21. Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach.
    Hartinger CG; Tsybin YO; Fuchser J; Dyson PJ
    Inorg Chem; 2008 Jan; 47(1):17-9. PubMed ID: 18067289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action.
    Casini A; Karotki A; Gabbiani C; Rugi F; Vašák M; Messori L; Dyson PJ
    Metallomics; 2009 Sep; 1(5):434-41. PubMed ID: 21305148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteins.
    Piccioli F; Sabatini S; Messori L; Orioli P; Hartinger ChG; Keppler BK
    J Inorg Biochem; 2004 Jun; 98(6):1135-42. PubMed ID: 15149825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins.
    Marzo T; Navas F; Cirri D; Merlino A; Ferraro G; Messori L; Quiroga AG
    J Inorg Biochem; 2018 Apr; 181():11-17. PubMed ID: 29353085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aquation of the ruthenium-based anticancer drug NAMI-A: a density functional study.
    Besker N; Coletti C; Marrone A; Re N
    J Phys Chem B; 2008 Apr; 112(13):3871-5. PubMed ID: 18331025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA structural distortions induced by ruthenium-arene anticancer compounds.
    Gossens C; Tavernelli I; Rothlisberger U
    J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiently detecting metallodrug-protein adducts: ion trap versus time-of-flight mass analyzers.
    Meier SM; Babak MV; Keppler BK; Hartinger CG
    ChemMedChem; 2014 Jul; 9(7):1351-5. PubMed ID: 24643974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mass spectrometric investigation of the ability of metal complexes to modulate transcription factor activity.
    Talib J; Beck JL; Urathamakul T; Nguyen CD; Aldrich-Wright JR; Mackay JP; Ralph SF
    Chem Commun (Camb); 2009 Oct; (37):5546-8. PubMed ID: 19753352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring metallodrug-protein interactions by ESI mass spectrometry: the reaction of anticancer platinum drugs with horse heart cytochrome c.
    Casini A; Gabbiani C; Mastrobuoni G; Messori L; Moneti G; Pieraccini G
    ChemMedChem; 2006 Apr; 1(4):413-7. PubMed ID: 16892376
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
    Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mass spectrometry in metallodrug development: a case of mapping transferrin-mediated transformations for a ruthenium(III) anticancer drug.
    Jarosz M; Matczuk M; Pawlak K; Timerbaev AR
    Anal Chim Acta; 2014 Dec; 851():72-7. PubMed ID: 25440667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: relevance to antitumour activity.
    Hartinger CG; Casini A; Duhot C; Tsybin YO; Messori L; Dyson PJ
    J Inorg Biochem; 2008 Dec; 102(12):2136-41. PubMed ID: 18834634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ion mobility mass spectrometry and a collision cross-section algorithm to study an organometallic ruthenium anticancer complex and its adducts with a DNA oligonucleotide.
    Williams JP; Lough JA; Campuzano I; Richardson K; Sadler PJ
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3563-9. PubMed ID: 19844963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a ruthenium(III)/NAMI-A adduct with bovine serum albumin that exhibits a high anti-metastatic activity.
    Liu M; Lim ZJ; Gwee YY; Levina A; Lay PA
    Angew Chem Int Ed Engl; 2010 Feb; 49(9):1661-4. PubMed ID: 20127775
    [No Abstract]   [Full Text] [Related]  

  • 35. Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands.
    Sacco F; Tarchi M; Ferraro G; Merlino A; Facchetti G; Rimoldi I; Messori L; Massai L
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomolecule binding vs. anticancer activity: reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins.
    Meier SM; Hanif M; Kandioller W; Keppler BK; Hartinger CG
    J Inorg Biochem; 2012 Mar; 108():91-5. PubMed ID: 22420927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.
    Casini A; Gabbiani C; Michelucci E; Pieraccini G; Moneti G; Dyson PJ; Messori L
    J Biol Inorg Chem; 2009 Jun; 14(5):761-70. PubMed ID: 19288144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A highly flexible dinuclear ruthenium(II)-platinum(II) complex: crystal structure and binding to 9-ethylguanine.
    van der Schilden K; Garcìa F; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    Angew Chem Int Ed Engl; 2004 Oct; 43(42):5668-70. PubMed ID: 15495144
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactions of PtII diamine anticancer complexes with trypanothione and octreotide.
    Munk VP; Fakih S; Socorro Murdoch PD; Sadler PJ
    J Inorg Biochem; 2006 Dec; 100(12):1946-54. PubMed ID: 17046064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.